Descovy
Payments companies reported to CMS as associated with Descovy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Descovy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Descovy
These are the largest totals companies reported as associated with Descovy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Wilfredo Giordano-Perez | Johnston, RI | Family Medicine | $127,048.00 |
| Noah Lee | Oakland Park, FL | Family Medicine | $102,504.12 |
| Michael Sension | Fort Lauderdale, FL | Internal Medicine | $87,019.90 |
| Jorge Rodriguez | Palm Springs, CA | Internal Medicine | $79,195.97 |
| Douglas Cunningham | Phoenix, AZ | Family Medicine | $76,393.13 |
| Theo Hodge | Washington, DC | Infectious Disease | $72,383.84 |
| Paul Benson | Berkley, MI | Family Medicine | $61,350.37 |
| Brian Beesley | Columbus, OH | Family Medicine | $56,244.51 |
| Jay Gladstein | Los Angeles, CA | Infectious Disease | $54,780.09 |
| Zane Saul | Stratford, CT | Infectious Disease | $54,688.66 |
Prescribed Descovy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.